Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Vericel Corporation, 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
SCYNEXIS Inc. June 25, 202589.9%
-
SCYNEXIS Inc. June 19, 202490.7%
-
Akebia Therapeutics Inc. June 6, 202469.1%
-
Vericel Corporation May 1, 202497.5%
-
SCYNEXIS Inc. June 14, 202393.6%
-
Vericel Corporation May 3, 202394.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 26, 2025 | SCYNEXIS Inc. | Grant or award | +23,000 | — | — |
| Jun 10, 2025 | Akebia Therapeutics Inc. | Grant or award | +35,700 | — | — |
| Oct 16, 2024 | Vericel Corporation | Option exercise | +5,833 | $13.05 | $76,121 |
| Oct 16, 2024 | Vericel Corporation | Open-market sale | −5,833 | $41.36 | $241,253 |
| Oct 2, 2024 | Vericel Corporation | Option exercise | +5,833 | $13.05 | $76,121 |
| Oct 2, 2024 | Vericel Corporation | Open-market sale | −5,833 | $40.35 | $235,362 |
| Sep 18, 2024 | Vericel Corporation | Option exercise | +5,834 | $13.05 | $76,134 |
| Sep 18, 2024 | Vericel Corporation | Open-market sale | −5,834 | $45.54 | $265,680 |
| Sep 4, 2024 | Vericel Corporation | Option exercise | +5,000 | $3.74 | $18,700 |
| Sep 4, 2024 | Vericel Corporation | Open-market sale | −5,000 | $48.58 | $242,900 |
| Jun 20, 2024 | SCYNEXIS Inc. | Grant or award | +23,000 | — | — |
| Jun 6, 2024 | Akebia Therapeutics Inc. | Grant or award | +30,000 | — | — |
| May 1, 2024 | Vericel Corporation | Option exercise | +3,200 | — | — |
| Jun 15, 2023 | SCYNEXIS Inc. | Grant or award | +10,000 | — | — |
| Jun 6, 2023 | Akebia Therapeutics Inc. | Grant or award | +30,000 | — | — |
Questions about Steven C. Gilman
What boards is Steven C. Gilman on?
Steven C. Gilman sits on the boards of Akebia Therapeutics Inc., SCYNEXIS Inc. and Vericel Corporation.
How long has Steven C. Gilman served on boards?
Our records show at least 10 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.